FindTrial
Sign In

Assigning risk levels in tongue cancers patinets based on genomics and immune patterns and understanding how to manage them optimally.

Step up protocol for tongue cancer - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078690
Enrollment
100
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C029- Malignant neoplasm of tongue, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

HealthCare Global Enterprises Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Squamous Cell Carcinoma of the Tongue - Stage 1-4 Non-Metastatic lesions

Exclusion criteria

Exclusion criteria: - Non-Squamous cell histology - Metastatic Cancers - Recurrent tumors

Design outcomes

Primary

MeasureTime frame
Disease Free SurvivalTimepoint: 1 year, 2 year, 5 year—

Secondary

MeasureTime frame
Overall SurvivalTimepoint: Till death;Proportion of Hot Tumors (Tumor Infiltrating Lymphocytes)Timepoint: At the time of diagnosis;Genomics by TSO500Timepoint: During initial diagnosis and upon recurrence—

Countries

India

Contacts

Public ContactDr Krithikaa Sekar

HealthCare Global Enterprises Ltd

drkrithikaa.s@hcgel.com9600455254

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026